US approval for a combination pill that is designed for people who suffer from high cholesterol levels and diabetes which will provide patients respite from spending too much for their medication.
Merck & Co (NYSE:MRK) was able to develop Juvisync which is set to be introduced into the market soon. This medicine for high cholesterol levels and diabetes is a combination of the Zocor and the Januvia pills of the company. These pills cost around $30 and $215 per month respectively. According to Duke University Medical Center endocrinologist, Dr. Susan Spratt, the medicine will facilitate the regimen of patients and enhance observance.
Since a number of diabetes patients have around six pills to take each day for high cholesterol levels, diabetes and blood pressure, it will not be easy for them to be consistent in taking them which will also cost even if they have health insurance.
Spratt added that patients will find it helpful for expenses to go down and when they strictly observe their medical requirements, health expenses can further be reduced.
A good number of the diabetes patients in the United States also suffer from high cholesterol levels since the two conditions are normally connected to being overweight. A combination of diabetes and high cholesterol levels would also increase the risk of kidney disease, stroke, and heart disease.
Other risks that diabetes patients include amputations from injuries that are not healed, blindness, as well as heart attacks. In spite of these risks, a number of patients are not following the recommended medication for their ailments.
The pill has six different dosages to take care of the different diabetes and cholesterol levels. Among the side effects for the medicine are stomach and muscle pain, headache, sore throat and stuffy nose.
Following the FDA approval in the United States, the company aims to have Juvisync approved for use in other countries to give relief to persons who suffer from diabetes and high cholesterol levels.